Home > Insider Trading > Filing (0001593968-22-000748)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
738214	Aemetis Inc	AMTX	Industrial Organic Chemicals (2860)	261407544

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1055711	R John Block	20400 Stevens Crek Blvd, Suite 700 Cupertino CA 95014		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2022-03-14	35,000	$12.12	54,627	No	4	S	Direct
Common Stock	Disposition	2022-03-14	35,000	$1.72	89,627	No	4	M	Direct
Common Stock	Disposition	2022-03-14	1,300	$12.12	53,327	No	4	S	Direct
Common Stock	Disposition	2022-03-14	18,865	$12.12	34,462	No	4	S	Direct
Common Stock	Acquisiton	2022-03-14	10,371	$12.12	24,091	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock And Series B Preferred	Option (right to buy)	Disposition	2022-03-14	35,000	$1.72	35,000	$1.72

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2017-01-20	2027-01-19	No	4	M	Direct

Footnotes

35,000 shares, which were acquired by exercising the NQ options granted on 1/19/2017 and were sold on 3/14/2022 in the open market.
35,000 shares, which were acquired by exercising the NQ options granted on 1/19/2017.
1,300 shares, which were acquired from the RSA grant on 1/7/2021, were sold on 3/14/2022 in the open market.
18,865 shares, which were acquired from the RSA grant on 4/8/2021, were sold on 3/14/2022 in the open market.
10,371 shares, which were acquired from the RSA grant on 1/6/2022, were sold on 3/14/2022 in the open market.
As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 24,091 shares of the Issuers common stock.